Avadel Pharmaceuticals (AWK.F) Q2 2024 Earnings

8MayConfirmed
Q4 2023
Q2 2024
-0.29
-0.27
-0.24
-0.22

Details

Expected EPS
-0.21629475
Actual EPS
-0.27909
Surprise EPS
-0.06
Surprise Percent
+29.03%

Description

Avadel Pharmaceuticals (AWK.F) has reported earnings of -0.27909 per share for Q2 2024.

0 Comments

Share your thoughts